Stockreport

OS Therapies Receives Patent Notice of Allowance from U.S. Patent & Trademark Office Covering Commercial Manufacturing of OST-HER2 [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF NEW YORK, February 20, 2025 BUSINESS WIRE )--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conju [Read more]